Profound Medical Corp. (TSX:PRN)
Canada · Delayed Price · Currency is CAD 9.66
-0.20 (-2.03%)
Jul 23, 2026, 4:00 PM EST
Profound Medical Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 18.81 | 16.1 | 10.68 | 7.2 | 6.68 | 6.87 |
Revenue Growth | 58.61% | 50.73% | 48.35% | 7.75% | -2.79% | -5.90% |
Gross Profit Gross Profit Growth | 13.37 | 11.39 | 7.04 | 4.31 | 3.02 | 2.95 |
Operating Income Operating Income Growth | -38.11 | -41.25 | -33.06 | -28.65 | -32.13 | -30.29 |
Net Income Net Income Growth | -38.9 | -42.57 | -27.82 | -28.32 | -28.67 | -30.7 |
Earnings Per Share EPS Growth | 1.24 | 1.41 | 1.12 | 1.34 | 1.38 | 1.50 |
EPS Growth | 1.64% | 25.89% | -16.42% | -2.90% | -8.00% | 20.00% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Germany Germany Growth | 0.7 | 0.77 | 0.89 | 1.84 | 1.8 | 2.71 |
Canada Canada Growth | 5.8 | 3.08 | 2.44 | 0.23 | 1.49 | 2.08 |
United States of America (USA) United States of America (USA) Growth | 12.32 | 12.25 | 7.35 | 5.13 | 3.4 | 2.09 |
Total Total Growth | 18.81 | 16.1 | 10.68 | 7.2 | 6.68 | 6.87 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 50.3 | 59.72 | 54.91 | 26.21 | 46.52 | 67.15 |
Total Debt Total Debt Growth | 7.46 | 4.71 | 5.12 | 7.87 | 8.23 | 1.38 |
Net Cash (Debt) Net Cash Growth | 42.83 | 55.01 | 49.79 | 18.35 | 38.29 | 65.78 |
Net Cash Growth | 3.08% | 10.48% | 171.40% | -52.08% | -41.79% | -20.02% |
Net Cash Per Share Net Cash Per Share Growth | 1.35 | 1.82 | 2.01 | 0.87 | 1.84 | 3.21 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -38.51 | -38.21 | -23.45 | -22.61 | -25.8 | -22.36 |
Capital Expenditures CapEx Growth | - | -0.18 | - | - | - | -0.03 |
Free Cash Flow Free Cash Flow Growth | -38.51 | -38.38 | -23.45 | -22.61 | -25.8 | -22.39 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 71.07% | 70.77% | 65.89% | 59.90% | 45.22% | 42.95% |
Operating Margin | -202.56% | -256.27% | -309.57% | -397.99% | -480.86% | -440.73% |
Pretax Margin | -205.51% | -262.88% | -260.47% | -395.21% | -424.82% | -445.13% |
Profit Margin | -206.76% | -264.44% | -260.45% | -393.43% | -429.11% | -446.66% |
FCF Margin | -204.67% | -238.43% | -219.60% | -314.06% | -386.17% | -325.80% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 5.57 | 6.72 | 6.25 | 7.73 | 7.52 |
PS Ratio | 13.37 | 17.69 | 21.17 | 24.84 | 33.35 | 34.11 |